Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chikako Ono

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Clinical and Experimental Nephrology|November 7, 2022
Establishment and clinical application of SARS-CoV-2 catch columnYoshitaka Isaka, Taku Yoshiya, Chikako Ono, et al.
Protein Science : a Publication of the Protein Society|September 13, 2025
Rational design of a covalent ACE2 decoy receptor that broadly neutralizes SARS-CoV-2 variantsNobumasa Hino, Risa Takada, Kyosuke Suzuki, et al.
The Journal of Experimental Medicine|October 8, 2021
Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related virusesRyo Shinnakasu, Shuhei Sakakibara, Hiromi Yamamoto, et al.
Frontiers in Immunology|November 12, 2024
BCR, not TCR, repertoire diversity is associated with favorable COVID-19 prognosisFaith Jessica Paran, Rieko Oyama, Abdullah Khasawneh, et al.
Plos Pathogens|February 9, 2026
Regnase-1-mediated regulation of neutrophils modulates SARS-CoV-2 pneumoniaKeiko Yasuda, Junichi Aoki, Kotaro Tanaka, et al.
The Journal of Experimental Medicine|December 13, 2022
Antibody feedback contributes to facilitating the development of Omicron-reactive memory B cells in SARS-CoV-2 mRNA vaccineesTakeshi Inoue, Ryo Shinnakasu, Chie Kawai, et al.
Plos Pathogens|May 12, 2017
Characterization of miR-122-independent propagation of HCVChikako Ono, Takasuke Fukuhara, Daisuke Motooka, et al.
Microbiology Spectrum|December 1, 2021
Correlation of the Commercial Anti-SARS-CoV-2 Receptor Binding Domain Antibody Test with the Chemiluminescent Reduction Neutralizing Test and Possible Detection of Antibodies to Emerging VariantsYoshitomo Morinaga, Hideki Tani, Yasushi Terasaki, et al.
Viruses|August 10, 2021
DsRNA Sequencing for RNA Virus Surveillance Using Human Clinical SamplesTakuma Izumi, Yuhei Morioka, Syun-Ichi Urayama, et al.
Nature Communications|June 18, 2021
Combining machine learning and nanopore construction creates an artificial intelligence nanopore for coronavirus detectionMasateru Taniguchi, Shohei Minami, Chikako Ono, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Clinical and Experimental Nephrology|November 7, 2022
Establishment and clinical application of SARS-CoV-2 catch columnYoshitaka Isaka, Taku Yoshiya, Chikako Ono, et al.
Protein Science : a Publication of the Protein Society|September 13, 2025
Rational design of a covalent ACE2 decoy receptor that broadly neutralizes SARS-CoV-2 variantsNobumasa Hino, Risa Takada, Kyosuke Suzuki, et al.
The Journal of Experimental Medicine|October 8, 2021
Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related virusesRyo Shinnakasu, Shuhei Sakakibara, Hiromi Yamamoto, et al.
Frontiers in Immunology|November 12, 2024
BCR, not TCR, repertoire diversity is associated with favorable COVID-19 prognosisFaith Jessica Paran, Rieko Oyama, Abdullah Khasawneh, et al.
Plos Pathogens|February 9, 2026
Regnase-1-mediated regulation of neutrophils modulates SARS-CoV-2 pneumoniaKeiko Yasuda, Junichi Aoki, Kotaro Tanaka, et al.
The Journal of Experimental Medicine|December 13, 2022
Antibody feedback contributes to facilitating the development of Omicron-reactive memory B cells in SARS-CoV-2 mRNA vaccineesTakeshi Inoue, Ryo Shinnakasu, Chie Kawai, et al.
Plos Pathogens|May 12, 2017
Characterization of miR-122-independent propagation of HCVChikako Ono, Takasuke Fukuhara, Daisuke Motooka, et al.
Microbiology Spectrum|December 1, 2021
Correlation of the Commercial Anti-SARS-CoV-2 Receptor Binding Domain Antibody Test with the Chemiluminescent Reduction Neutralizing Test and Possible Detection of Antibodies to Emerging VariantsYoshitomo Morinaga, Hideki Tani, Yasushi Terasaki, et al.
Viruses|August 10, 2021
DsRNA Sequencing for RNA Virus Surveillance Using Human Clinical SamplesTakuma Izumi, Yuhei Morioka, Syun-Ichi Urayama, et al.
Nature Communications|June 18, 2021
Combining machine learning and nanopore construction creates an artificial intelligence nanopore for coronavirus detectionMasateru Taniguchi, Shohei Minami, Chikako Ono, et al.
Pageof 9